Abeona Therapeutics Stock Price on November 19, 2024
| ABEO Stock | USD 6.41 0.38 6.30% |
Below is the normalized historical share price chart for Abeona Therapeutics extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Abeona Therapeutics stands at 6.41, as last reported on the 30th of November, with the highest price reaching 6.55 and the lowest price hitting 6.01 during the day.
If you're considering investing in Abeona Stock, it is important to understand the factors that can impact its price. Abeona Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Abeona Therapeutics secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Abeona Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Abeona Therapeutics' mean deviation of 1.99, and Risk Adjusted Performance of 0.0771 to double-check if our risk estimates are consistent with your expectations.
At this time, Abeona Therapeutics' Issuance Of Capital Stock is very stable compared to the past year. . At this time, Abeona Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 30th of November 2024, Price Earnings To Growth Ratio is likely to grow to 0.06, while Price To Sales Ratio is likely to drop 29.07. Abeona Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of September 1980 | 200 Day MA 5.7609 | 50 Day MA 6.2416 | Beta 1.505 |
Abeona |
Sharpe Ratio = 0.1116
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ABEO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.58 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.29 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Abeona Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abeona Therapeutics by adding it to a well-diversified portfolio.
Price Book 6.0686 | Enterprise Value Ebitda (0.58) | Price Sales 61.6302 | Shares Float 28 M | Wall Street Target Price 16.75 |
Abeona Therapeutics Main Headline on 19th of November 2024
ABEO FDA Accepts BLA Re-Submission for Pz-cel PDUFA Date of ... by finance.yahoo.com
By David Bautz, PhD NASDAQABEO READ THE FULL ABEO RESEARCH REPORT Business Update BLA Resubmission Accepted PDUFA Date of April 29, 2025 On November 12, 2024, Abeona Therapeutics, Inc. announced that the U.S. FDA has accepted the Biologics License Application for prademagene zamikeracel and set a PDUFA target action date of April 29, 2025. The resubmission of the
Abeona Therapeutics Valuation on November 19, 2024
It is possible to determine the worth of Abeona Therapeutics on a given historical date. On November 19, 2024 Abeona was worth 5.83 at the beginning of the trading date compared to the closed value of 5.89. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Abeona Therapeutics stock. Still, in general, we apply an absolute valuation method to find Abeona Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Abeona Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Abeona Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 5.82 | 5.91 | 5.63 | 5.86 | 737,077 | |
11/19/2024 | 5.83 | 5.93 | 5.77 | 5.89 | 251,941 |
| 5.90 | 6.01 | 5.64 | 5.75 | 215,836 |
| Backtest Abeona Therapeutics | | | Abeona Therapeutics History | | | Abeona Therapeutics Valuation | Previous | Next |
Abeona Therapeutics Trading Date Momentum on November 19, 2024
| On November 20 2024 Abeona Therapeutics was traded for 5.75 at the closing time. The top price for the day was 6.01 and the lowest listed price was 5.64 . The trading volume for the day was 215.8 K. The trading history from November 20, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.38% . The overall trading delta against the current closing price is 3.40% . |
Abeona Therapeutics Fundamentals Correlations and Trends
By evaluating Abeona Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Abeona Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Abeona financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Abeona Therapeutics Stock history
Abeona Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Abeona is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Abeona Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Abeona Therapeutics stock prices may prove useful in developing a viable investing in Abeona Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 21.4 M | 22.4 M | |
| Net Loss | -39.1 M | -41.1 M |
Abeona Therapeutics Quarterly Net Working Capital |
|
Abeona Therapeutics Stock Technical Analysis
Abeona Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Abeona Therapeutics Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Abeona Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Abeona Therapeutics November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Abeona Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Abeona Therapeutics shares will generate the highest return on investment. By undertsting and applying Abeona Therapeutics stock market strength indicators, traders can identify Abeona Therapeutics entry and exit signals to maximize returns
Abeona Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Abeona Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Abeona Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Abeona to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0771 | |||
| Jensen Alpha | 0.1781 | |||
| Total Risk Alpha | (0.21) | |||
| Sortino Ratio | 0.04 | |||
| Treynor Ratio | 0.5844 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.05) | Quarterly Revenue Growth (1.00) | Return On Assets (0.38) | Return On Equity (1.27) |
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abeona Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.